MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Commercial Launch of ChrgD+
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the commercial launch of ChrgD+, the industry’s most advanced water-soluble multi-spectrum hemp oil in a powdered format and empowered…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Joint Manufacturing Partnership Opens Door to Widespread Distribution
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a biotechnology company and drug-delivery platform innovator, is increasing the reach of its revolutionary DehydraTECH(TM) technology that enables the rapid onset of ingested cannabis. An article discussing the company…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Drug-Delivery Platform Could Help Smokers Stub Cigarettes
Lexaria recently announced its entry into a partnership with a tobacco giant to fund the research and development of oral nicotine delivery solutions The company received a cannabis R&D license from Health Canada LXRP also…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) R&D Finds Lack of Adverse Chemical Byproducts in Manufacture of Drug Delivery Compositions
Lexaria Bioscience is involved in the research and improvement of its trademarked DehydraTECH technology, which enhances the bioavailability of some legal drug substances used by consumers The technology provides a rapid-on, rapid-off effect that may…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Four New Patents, Increasing Total Granted to 15
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the granting of four of its pending patent applications via its wholly-owned subsidiary Poviva Corp. According to the update,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appoints Consumer Packaged Goods Veteran to Board of Directors
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the appointment of Brian Quigley to its board of directors. Quigley most recently spent 16 years at Altria Group,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Subsidiary Receives Health Canada Cannabis R&D License
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Completes Initial R&D Program with the National Research Council of Canada
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced successful completion of its Master Collaborative Research Agreement (“the R&D Program”) with the National Research Council of Canada (“NRC”). The…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reviews Expansion of Client Base, Noting Unprecedented Number of License Agreements
Lexaria’s patented DehydraTECH technology improves taste, achieves higher absorption rates and promotes fast onset of bioactive compounds, including nicotine and cannabinoids Nine corporate licensees have signed a total of 11 definitive contracts to use DehydraTECH technology…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Paves Way for New Cannabis Brand, B2B Sales through Partnership with Alcohol-Free Beverage Maker
Lexaria Bioscience’s revolutionary DehydraTECH technology enables cannabis consumers to experience rapid-on, rapid-off effects in non-smoked formulations A just-announced joint manufacturing partnership between Lexaria and alcohol-free beverage maker Hill Street Beverage Company is paving the way…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Retains Integra Consulting Group LLC to Provide Investor Relations Services
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that it has engaged Integra Consulting Group LLC to provide investor relations services to the company in compliance with…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Summarizes DehydraTECH(TM) Technology Licensees
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Agreement Increases Reach of Ingested Cannabis Absorption Technology
Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Manufacturing & Licensing Partnership with Hill Street Beverage Co. (TSX.V: BEER)
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Stands for Responsible Cannabis Use; Is the Industry Taking Adoption Too Far?
As the legal marijuana industry continues to rapidly expand, regulatory bodies in the U.S. and other parts of the world are facing lobby pressure to ensure widespread adoption Companies like Lexaria Bioscience have opposed such…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Consistently Outperforms Industry Standards
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM) can deliver eight times more CBD into the blood…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Partners with Nic’s Beverages in Definitive CBD Beverage License Agreement
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages L.L.C. Under the…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leading the Way in Effective Cannabis Treatment
Lexaria developed and out-licenses DehydraTECH to create new (and improve existing) drug-delivery products The company is credited with leading the way forward in discovering new ways to effectively deliver CBD into the human body Lexaria…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial